Detection rates of trichomonas vaginalis, in different age groups, using real-time polymerase chain reaction

Journal of Lower Genital Tract Disease

Volumn 16, Issue 4, 2012, Pages 352-357

  Stemmer, Shlomo M ^a,b,c   Adelson, Martin E ^a   Trama, Jason P ^a   Dorak, M Tevfik ^a   Mordechai, Eli ^a  

^a Pharmacogenomics Division   (United States)

^b Department of Obstetrics and Gynecology ^*  (United States)

^c THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

age groups; Chlamydia trachomatis; PCR; Trichomonas vaginalis

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; FEMALE; GYNECOLOGICAL EXAMINATION; HUMAN; MAJOR CLINICAL STUDY; NEISSERIA GONORRHOEAE; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; TRICHOMONAS VAGINALIS; UNITED STATES;

ADOLESCENT; ADULT; AGED; CHILD; CHLAMYDIA TRACHOMATIS; FEMALE; FLORIDA; GONORRHEA; HUMANS; LYMPHOGRANULOMA VENEREUM; MIDDLE AGED; NEISSERIA GONORRHOEAE; NEW JERSEY; REAL-TIME POLYMERASE CHAIN REACTION; TEXAS; TRICHOMONAS INFECTIONS; TRICHOMONAS VAGINALIS; YOUNG ADULT;

EID: 84867578612     PISSN: 10892591     EISSN: 15260976     Source Type: Journal    
DOI: 10.1097/LGT.0b013e31824b9be2     Document Type: Article

References (30)

1. Cates W Jr. Estimates of the incidence and prevalence of sexuallY transmitted diseases in the United States. Sex Transm Dis 1999;23:415-24.
2. Weinstock H, Berman S, Cates W Jr. SexuallY transmitted diseases among American Youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004;36:6-10.
3. MoodleY P, ConnollY DW, MoodleY J, Sturm W. Trichomonas vaginalis is associated with pelvic inflammatorY diseases in women infected with HIV. Clin Infect Dis 2002; 34:519-22.
4. Sherman KJ, Daling JR,Weiss NS. SexuallY transmitted disease and tubal infertilitY. Sex Transm Dis 1987;14:12-6.
5. Cotch MF, Pastorek JG, Nugent RP, Hillier SL, Gibbs RS, Martin DH, et al. Trichomonas vaginalis associated with low birth weight and preterm deliverY. Sex Transm Dis 1997; 24:361-2.
6. Minkoff H, Grunebaum AN, Schwarz RH, Feldman J, Cummings M, Crombleholme W. Risk factors for prematuritY and premature rupture of membranes: a prospective studY of the vaginal flora in pregnancY. Am J Obstet GYnecol 1984; 150:965-72.
7. Gottlieb SL, Douglas JM, Foster M, Schmid DS, Newman DR, Bolan A, et al. Incidence of herpes simplex virus tYpe 2 infection in 5 sexuallY transmitted disease (STD) clinics and the effect of HIV/STD risk-reduction counseling. J Infect Dis 2004;190:1059-67.
8. Sorvillo F, Smith L, Kerndt P, Ash L. Trichomonas vaginalis, HIV, and African-American. Emerg Infect Dis 2002; 8:749.
9. Gram IT, Macaluso M, Churchill J, Stalsberg H. Trichomonas vaginalis and human papillomavirus infection and the incidence of cervical intraepithelial neoplasia grade III. Cancer Causes Control 1992;3:231-6.
10. Soper DE, Bump RC, Hurt WG. Bacterial vaginosis and Trichomonas vaginalis are risk factors for cuff cellulitis after abdominal hYsterectomY. Am J Obstet GYnecol 1990; 163:1016-21.
11. Wolner-Hanssen P, Kreiger JN, Stevens CE, Kiviat NB, Koutsk- L, Critchlow C, et al. Clinical manifestations of vaginal trichomoniasis. JAMA 1989;261:571.
12. Sobel JD. Vaginitis.NEngl J Med 1997;337:1896-903.
13. McCann JS. Comparison of direct microscopY and culture in the diagnosis of trichomoniasis. Br J Vener Dis 1974; 50:450-2.
14. Garber GE, Sibau L, Ma R, Proctor EM, Shaw CE, Bowie WR. Cell culture compared with broth for detection of Trichomonas vaginalis. J Clin Microbiol 1987;25:1275-9.
15. Caliendo AM, Jordan JA, Green AM, Ingersoll J, Diclemente RJ, Wingood GM. Real-time PCR improves detection of Trichomonas vaginalis infection compared with culture using self-collected vaginal swabs. Infect Dis Obstet GYnecol 2005;13:145-50.
16. KaYdos CS, SwYgard H, Wise SL, Sena AC, Leone PA, Miller WC, et al. Development and validation of PCR based enzYme-linked immunosorbent assaY with urine for use in clinical research settings to detect Trichomonas vaginalis in women. J Clin Microbiol 2002;40:89-95.
17. OhlemeYer CL, Hornberger LL, LYnch DA, Swierkosz EM. Diagnosis of Trichomonas vaginalis in adolescent females: InPouch TV culture versus wet-mount microscopY. J Adolesc Health 1998;22:205-8.
18. Bachman LH, Lewis I, Allen R, Schwebke JR, Leviton LC, Siegal HA, et al. Risk and prevalence of treatable sexuallY transmitted diseases at a Birmingham substance abuse treatment facilitY. Am J Public Health 2000;90:1615-8.
19. Wiesenfeld HC, LowrY DL, Heine RP, Krohn MA, Bittner H, Kellinger K, et al. Self-collection of vaginal swabs for the detection of ChlamYdia, gonorrhea, and trichomoniasis: opportunitY to encourage sexuallY transmitted disease testing among adolescents. Sex Transm Dis 2001;34(7):321-5.
20. Bowden FJ, Garnett G. Trichomonas vaginalis epidemiologY: parameterising and analYsing a model of treatment interventions. Sex Transm Infect 2000;76:248-56.
21. Miller WC, Ford CA, Morris M, Handcock MS, Schmitz JL, Hobbs MM, et al. Prevalence of chlamYdial and gonococcal infections among Young adults in the United States. JAMA 2004;291:2229-36.
22. Thornton AC, Dale T, FortenberrY D, Logan TK. Occurrence of trichomoniasis in college women [abstr]. #0386 ISSTDR 2003; JulY 27-30; Ottawa, Canada.
23. Shafer MA, Moncada J, BoYer CB, Betsonger K, Flinn, SD, Schacter J. Comparing first-void urine specimens, selfcollected vaginal swabs, and endocervical specimens to detect ChlamYdia trachomatis and Neisseria gonorrhea bY nucleic acid amplification test. J Clin Microbiol 2003;41:4395-9.
24. Sutton M-, Sternberg M, Kouman E, McQuillan G, Berman S, Markowitz L. The prevalence of Trichomonas vaginalis in the United States, 2001-2002. Obstet GYnecol 2006;107:S8.
25. Sutton MY, Sternberg M, Kouman E, McQuillan G, Berman S, Markowitz L. The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004. Clin Infect Dis 2007;45:1319-26.
26. Bowden FJ, Paterson BA, Mein J, Savage J, FairleY CK, Garland SM, et al. Estimating the prevalence of Trichomonas vaginalis, ChlamYdia trachomatis, Neisseria gonorrhoeae and human papillomavirus in indigenous women in northern Australia. Sex Transm Infect 1999;75:431-4.
27. Soper D. Trichomoniasis: under control or undercontrolled? Am J Obstet GYnecol 2004;190:281-90.
28. Sobel JD, Nagappan V, NYirjesY P. Metronidazoleresistant vaginal trichomoniasis an emerging problem. N Engl J Med 1999;341:292-3.
29. Sobel JD, NYirjesY P, Brown W. Tinidazole therapY for metronidazole-resistant vaginal trichomoniasis. Clin Infect Dis 2001;33:1341-6.
30. Schmid G, Narcisi E, Mosure D, Secor WE, Higgins J, Moreno H. Prevalence of metronidazole resistant Trichomonas vaginalis in a gYnecologY clinic. J Reprod Med 2001;46: 545-9.